Lifeloc Technologies Inc (PK) (LCTC) Noticias

Since Lifeloc is a global company, and has customers all over the world, sales will probably be dependent on local laws in the country/state they are doing business in.

In the U.S., the Department of transportation (DOT), has set cutoff limits for THC at 4ng/ml for initial test, and 2ng/ml for the confirmatory test. They have a list of other commonly abused drugs, along with their cutoff limits - most of which Lifeloc's SpinDx is said to be able to detect, and will be implemented in the future. https://www.transportation.gov/odapc/part40/40-91

The DOT limits are set for the transportation and pipeline industry - airlines, railways, trucking. There are also mandatory guidelines for Federal workplace drug testing set by the SAMHSA. https://www.federalregister.gov/documents/2023/10/12/2023-21735/mandatory-guidelines-for-federal-workplace-drug-testing-programs

These guidelines by the SAMHSA, have been established for oral fluid drug testing of Federal Employees. As far as driving under the influence of marijuana, each state has it's own laws...

Marijuana Drug-Impaired Driving Laws
18 states have zero tolerance or non-zero per se laws for marijuana.

10 states have zero tolerance for THC or a metabolite.
4 states have zero tolerance for THC but no restriction on metabolites.
4 states have specific per se limits for THC
1 state (Colorado) has a permissible inference law for THC

As marijuana use continues to grow in the United States (more people in the U.S. now use marijuana daily than consume alcohol), impaired driving under the influence of THC has become a growing concern by both society, and governmental regulators. For this reason, states will come under scrutiny to establish stricter regulations regarding DUI of THC. It's my opinion, that most states will eventually adopt the guidelines set in place by both the DOT, and SAMHSA for driving under the influence of THC. Each state will also independently decide confirmatory, laboratory testing of the split oral fluid sample, by utilizing labs chosen for their state.

It's coming... maybe not today or tomorrow, but in the very near future.

I think that the beta testing will provide data for potential customers to evaluate. I don't think that sales will be held up by lack of certified lab verification.

Good morning ! I always take all comments and points of view in consideration - whether negative, or positive. I understand, and share your frustration, but you have to understand that management can't simply make fluffy posts and press releases about a product, that have not occurred yet, or are not valid. This would just create a huge legal problem, with investor lawsuits, etc...

Insiders buy and sell stock for many reasons. This company is primarily owned by insiders, and all recent insider trades over many years were all Buys. Due to this large insider ownership, there are very few shares to actively trade on the open market. The handful of retail investors, like the three of us, understand this, and also understand that this creates very low trading volume in the stock. Unfortunately, this very low volume is unattractive to most short term traders - where the stock may not even trade for several days.

As a long term investor, my hopes are that this product comes to fruit. We see increased share price, with increased volume. With product sales, we see large revenue increases, increased investor awareness, increased awareness of the Lifeloc Brand and it's products. Of course, we must first see a viable device, that must meet rigorous standards before it can be marketed and sold. My personal opinion is that this device is near completion, as management has expressed. The testing and validation of this equipment will become the focus in the near term. There will probably be some obstacles to overcome, but as management has stated, they believe the SpinDx Oral Fluid Device will be widely accepted.

Even if we had a marketable oral fluid device to sell 6 months ago, it would be basically useless, until we have certified Labs in the U.S. to verify the readings of the devices split oral fluid sample. To my knowledge, there are still no labs certified for the oral fluid testing of THC in the United States. The certification of U.S. labs for the testing of THC in an oral fluid sample will be an external milestone to the development of the SpinDx device.

The current trend in drug testing is oral fluid. Lifeloc was correct in focusing their efforts, by first developing a device for the detection of THC in oral fluid. There is current training beginning to occur, to train people to train people to do oral fluid testing - basically training the trainers, as well as actual training to certify someone in "oral fluid testing." There are strict protocols that must be met during the testing, with the equipment, as well as the sample for a valid test. To the best of my knowledge, this training is not specific to one kind of a device - although there are standards that each device must meet, such as a utilizing a split sample for lab validation, translucent collection tubes with lot #, etc... If you Google this topic, you will find hours of reading on very current developments in this area. Not only that, but you will also find that many of the trainers in the oral fluid field, are also Lifeloc certified trainers in alcohol testing.

Press releases will come. Public Relations on social media will come - all when due. Until then, patience is the best tool, no matter how frustrating that may be in the short term.

Vern did buy a lot of shares at $3.80 and I don't think he would have unless he believed things would work out. Beyond that I don't know, I agree they could do a lot better on the social media front. There have been a lot of delays, but I think that's typical for a small company that needs more capital. I'm hoping/betting this is the year we see some progress.

Allow me to rant during this post. If you prefer not to hear anything negative then please don't read the following message:

We have asked over and over again for the team at Lifeloc to utilize social media. It's cost effective, easy to do, reaches a worldwide audience, helps to gain exposure, produces results, etc. I know of plenty of small businesses that have utilized tik tok and Instagram to expand their business exponentially and Lifeloc still refuses to put any effort whatsoever into social media.

Lifeloc should be growing it's core alcohol business by at least 10% a year and yet we will probably see the year 2024 with a decrease in sales/revenues. Lifeloc should be a company with easily over $10 million in revenue at this point. The sector is seeing explosive worldwide and domestic growth and Lifeloc is not participating.

In this current stock market bull run, 95% of all other publicly traded companies have performed better than Lifeloc. We sit near 52 week lows and not that far from all-time lows. Wayne Wilkomm may be a wonderful engineer, but I'm not convinced he knows how to run a public company.

As far as the seller camped out at $39.00 with 15,000 shares for sale, it would take an absolute miracle for Lifeloc to trade that high with the current management team in place. I wish you all the best but until we see some changes, we will not get anywhere close to new all-time highs.

It just feels like all interest has been lost in this company. There has not been an article written about them from an outside source in years, buyers of the stock are nowhere to be found, we were basically promised news by the end of last year and nothing, and the earnings reports fail to report any new information. Are we going to get the quarterly earnings report in March only to read that it has been pushed back once again: "The start of beta testing of our SpinDx saliva testing system utilizing the delta-9-THC disks is expected later in 2025 and is projected to result in commercialization of our first SpinDx application in 2026." Are we the crazy "insane" one's expecting that something will be different this time around. This is the 5th year of the same old - same old. The team at Lifeloc has had the prototype of the SpinDx device for 3,000 days and every year it gets pushed back.

Insiders have not purchased any shares in the current $2.00 range. It they were nearing completion, I would expect someone from the team at Lifeloc to make a purchase at these current price levels and keep it supported. If the engineer was finishing up the final touches, don't you think they would purchase some shares here near all time lows?

To the team at Lifeloc technologies - You can do better or we need to see some changes.

I know only 3 or so people will even read this but someone please tell me I'm wrong and this is the year everything works out perfectly for Lifeloc.

Wouldn't it be nice if someone could develop a roadside device to measure recent use THC levels, to help solve this dilemma...
https://www.nytimes.com/2025/01/01/us/marijuana-driving-impairment.html#

Interesting.... Someone has a $585,000 sell order in at $39.00 a share (15,000 shares)... Current short interest is relatively high, with 2200 shares sold short on 12/26. I feel some fireworks coming...

LCTC share price now sits approximately 85 cents off of it's 52 week low. It is also currently priced approximately 30% below a recent, large insider buy at $3.80 per share by the company's Chief Financial Officer. The company has huge insider ownership of almost 90% of company, with EDCO Partners owning almost 78% alone... Get it while you can...

LDCT with more than a 400% move today. 1 letter away.

Maybe one day we will wake up to news that moves LCTC over 400%.

I am still a bit disheartened about not getting a SpinDx update yet. I feel like the team at Lifeloc owed us at least that much.

A little food for thought from the DEA...

https://www.justthinktwice.gov/sites/default/files/2022-12/Impaired%20Driving%20Fact%20Card%20Web.pdf?utm_medium=email&utm_source=govdelivery

A little food for thought from the DEA...

https://www.justthinktwice.gov/sites/default/files/2022-12/Impaired%20Driving%20Fact%20Card%20Web.pdf?utm_medium=email&utm_source=govdelivery

Normal trading. Don't watch every tick, and don't get stopped out.... Going much higher...

Is this tax-loss selling going on or something else?

I believe the CEO stated that he felt that the device would be widely accepted. As far as accuracy, yes this is important, and I believe from the recent report that they continue to have it down to 10ng/ml, with strives to improve on that. I do not know how the accuracy will compare to it's competitors, but I believe Lifeloc will have the most versatile device, with capabilities to test for a complete panel of drugs of abuse.

I'm sure that Lifeloc has done their testing in-house to evaluate a lot of the variables that can affect the outcomes of the test results, or they would not be releasing a prototype for Beta testing. There's a lot of things that can affect electronic equipment, including temperature, humidity, human error, etc... Most of these variables are rigorously tested in the lab or an environmental chamber - where you can adjust temperature, humidity, etc, and compare results.

I would not expect immediate acceptance of the device, because there is almost always adjustments that need to be made. This is why Lifeloc states that they expect commercialization later in 2025. This could surprise us and be sooner, or could drag out longer. Also keep in mind, that according to Andy Lehman, the majority holder, who is in his 90's, may be willing to basically sell the company for the "right price." At Lifeloc's current Market Cap, it is ripe for a merger or acquisition from bigger players in the field.

There is a limited number of shareholders, from my memory, it's only about 33. These shareholders are most likely long-term investors, vs. short term traders, which, I believe will hold the share price somewhat consistent. Not saying there may be a few spikes up or down, but any spike down would be a buying opportunity in my opinion, and downward pressure would probably be short lived - such as the big volume spike down that we saw back in June, which is when Mr. Lehman probably acquired the bulk of his shares.

I would love to see a news release about roadside testing of the SpinDx device and I hope your scenario plays out.  

Do you have any idea when we can learn about the accuracy of the SpinDx device?  Are we talking something that could be in the 99% or higher category?  When do we find out about false negatives and what can effect the results of the device?   Or is it as simple as yes it's in your system or no it's all clear. 

Do you think Lifeloc could have the most accurate and reliable drug detection device on the market or do the Draegers and Abbott Labs have it already locked down. 

Thanks! 

I agree that there was not much in the report to draw any interest to the stock. My point about the Beta testing, is that I don't see anyway around keeping it quiet. I feel that Lifeloc has probably been in talks about testing their new oral fluid test with their long list of customers over the past months. This includes many state and local police forces throughout the US, and the world.

The purpose of the testing, is to use a third party, outside of the Lifeloc team, to utilize the equipment as they would in day to day operations, and give feedback on the equipment's performance, any flaws, areas that need improvement, etc... Most manufacturers do this before they start to gear up for production of the equipment, so they can make any adjustments to the product, before they begin mass production. It was stated in the report that they wanted to do this before they began "tooling," which is the production set-up for the final product. This allows for any changes, in any of the parts used in the manufacturing process, such as dimension changes in injected molded parts, etc. This saves time and money over the long run, and gives the customer a better product.

Let's use this scenario... The New Jersey State Police agree to test out the new SpinDx product. They are currently being trained by Lifeloc trainers, and will begin testing the general population in 2 to 3 weeks, during routine traffic stops. In order for them to perform the test, they will have to get the participants agreement to take the test, and be informed that it will not be used against them in any way on a legal basis, because it is currently only being tested out by the state police.

Now I'm almost certain, that the New Jersey State Police would have to inform the public in advance, that they are going to begin this testing, of a new oral fluid test for the detection of drugs during traffic stops, and that it would not be used in a court of law, and it is only being performed for informational purposes only. I also believe, that local media, News networks, etc., would also be reporting on this new, roadside test that is being administered throughout the State of New Jersey.

Again, this is just a random scenario that I conjured up, but it's my opinion that this could occur within the next 6 weeks.

I just didn't see enough to get current investors or potential new investors excited. Lifeloc has a history of not making any news announcements between November and March and I just feel like we were promised a bit more than just the same old - same old.

However one new bit of news is the fact that Spin DX can now detect fentanyl:
"SpinDx has been demonstrated in our laboratory to effectively detect for delta-9-THC, cocaine, fentanyl, amphetamine methamphetamine, morphine, MDMA, and benzodiazepines."

Without new buying interest, history shows us that we will just trend downward with little to no volume. I hope I'm wrong but we could really use some news from Lifeloc that is outside of the quarterly reports.

Yes, a little frustrating. One positive is that they did re-iterate that Beta testing will begin this quarter. They didn't elaborate on this, but there is only 6 weeks remaining in the quarter. It appears that they have prototype units that are ready, or nearly ready for this testing. I would imagine that once the Beta testing commences, this would be public knowledge, due to that fact that it will most likely be law enforcement/police conducting the testing on the general public.

Quarterly results were not very good.  Their only excuse is the concentrated effort on bringing the SpinDx to market. 

I didn't see anything in the report that I would consider market moving that would attract any new buyers/investors.  So here we are again with the "later next year" wording.  

You would think with Vern getting into his mid 90's that the team at Lifeloc would want to fast-track this a bit so he could enjoy some of his Lifeloc stock investment.  

Without any further news, we have to watch this thing trickle back down in price and wait until March before we get the next update in the annual report. 

We could really use an update and news release that specifically talks about the SpinDx drug detection device separate from the earnings releases.  Sadly, I don't see that happening so once again we wait with little to no volume until next year.  

Lifeloc - you can do better! 

Not great quarterly results, but, "We are optimistic about the results of the work to date and expect market introduction via beta testing later in Q4 of 2024, which will continue in 2025, with a sales-ready device later in 2025."

I have to imagine Lifeloc reports it's quarterly earnings today after the close or tomorrow. I want to be as optimistic as you with hearing some good news about the beta testing but I'm not holding my breath on that one. A Trump presidency seems favorable to small/micro cap stocks but no so much to the marijuana/cannabis sector.

We could really use some market moving news from Lifeloc. Most other stocks are at all time highs in this market and Lifeloc really hasn't participated in any of this recent rally.

We know the Abbott labs, Draegers, and Hound Labs have valuations of 10 - 100 times that of Lifeloc but we need to hear some news about progress being made. I almost feel like we were promised something by year's end and it's quickly approaching.

Lifeloc should be reporting earnings within the next 10 trading days. Hopefully we will get some better insight of Beta testing of their new device - has it begun yet, who is doing the testing, etc...

Looking back to when I was first introduced to Lifeloc, and when I made my first trades in LCTC stock back around late 2016. I was buying in the $4 to $7 price range as more of a day trader, than investor back then. With news of the collaboration with Sandia Labs, and early stage development of the "THC Breathalyzer," the stock ran up into the low to mid $20's in a very short time. This was merely on news of early stage development of the device.

Now that we have seen years of consolidation in the stock price, and the product is near commercialization vs. simply news of early development, as in 2016/2017 - coupled with the current market sentiment of small cap companies making 10x moves in a day, wouldn't it be prudent to assume that a share price greater than the mid $20's is not only obtainable, but warranted? The Market Cap of this company currently sits at just over $10 Million dollars, which is miniscule, and actually considered Micro Cap. With the potential of this new device to increase revenue over $100 Million dollars, I still feel a mid $40's share price is substantiated. In comparison to it's peers, it is now grossly undervalued, even though it is "Best of Breed" in my opinion.

It just seems like an impatient investor sold 1,750 shares right at the close today.   Not sure if it's for tax loss selling purposes.  I don't see any other news that could explain it.  It had held the $4.00 level for so long.  It goes to show you that it's so thin in either direction that a couple thousand shares is going to move it dramatically.  

We are all expecting some news from this company and continue to get nothing.  It's not easy to see why someone would get frustrated and sell but I picked up more shares at $3.55 and $3.50 today 

any idea why the stock tanked?

Lifeloc is an exhibitor (Booth 2370) this weekend at the IACP conference in Boston, MA. I didn't realize this show had so many different companies attending including Drager and Axon.

Keep in mind that at the August ICAP Traffic and Safety Conference they stated:

"We discussed our upcoming saliva drug testing device which generated significant interest from attendees. We are excited to announce that we will begin initial beta testing later this year." During that week there was good volume in LCTC so my hope is the event this weekend will also bring in some increased interest in the stock.

You know that I am locked up and will not be selling any Lifeloc shares prematurely. I was still buying some shares on Friday to get it to the highs of the day. We really could use the catalyst to bring in more awareness and volume to the upside. It feels so thin that even a small news event could help this to explode. A handful of new investors is all it really takes.

I'd like to set us up on a call with Andy Lehman if your interested. It really feels like we are the only ones that have any vested interest in this company.

Arizona Court Of Appeals Marijuana Ruling Sends Risky Message To Drivers:

https://www.mondaq.com/unitedstates/cannabis/1531926/arizona-court-of-appeals-marijuana-ruling-sends-risky-message-to-drivers

Everyone is looking for a system or method that can determine impairment - "For marijuana, no such scientific standard currently exists, leaving law enforcement with a more subjective—and less reliable—method of determining impairment."

"While we're making progress toward the development of a THC breathalyzer that could establish a clear standard for marijuana impairment, it's now up to our lawmakers and law enforcement agencies to adopt such tools once available. The goal must be to create a standard that can reliably indicate when someone is truly impaired by marijuana, similar to the .08 limit for alcohol."

DRUG went from $2 a share 3 days ago, to $60 a share today. This kind of thing has been occurring all week....

If we do get some positive news, keep this in mind, and don't be too quick to sell your shares prematurely. I think $45 a share is very obtainable, and will put this where it is rightfully priced compared to it's peers...

Volume drying up can be a positive sign in technical analysis. It's often seen in "cup and handle" patterns, where selling pressure begins to diminish. Not saying it's exactly what's occurring here, OTC stocks don't always follow typical chart patterns. Hopefully we will have our day...

In the latest quarterly report from Lifeloc it was stated "Market introduction of SpinDx via beta testing later in 2024."

I hope we can get some type of an update from them while the low float small cap market is exploding. Volume has been dismal and it just feels like its so thin in both directions that it won't take much to get it moving.

Small Caps have been on fire this week. Some, rocketing over 1,000%. SOBR (in the same business as Lifeloc) is on fire again this morning, up over 100% in pre-Market.

There could not be a better time for Lifeloc to step up to the plate with the current market sentiment. Election is two weeks away, and earnings release probably not too far after that. Can we get just a little something...?

I’d really like to find out if we can expect any news from Lifeloc before year’s end.

Explosive moves like the one in DRUG happens with news announcements and catalysts which we haven’t had from Lifeloc in the longest time.

Can’t we just get some type of an update from management on the Spin DX progress before the new year?

Check out DRUG. Up over 1000% in a day. From $2 to $32.

Yes, I read his whole report on Lifeloc. Reinforces my analysis of the company.

His #of shares in the float seemed a little higher than what I thought it was, nonetheless, still one of the lowest floats in the entire market.

I also think he is being extremely cautious with his price projection of Lifeloc's share price in the next couple of years...

Amazingly excellent find. Good job !

Should we share his report to others, or keep it to ourselves, and try to add more to our positions...?

A bit disappointing to not have any volume or trades in Lifeloc after the SAPAA conference was done. Hopefully they received some information from attending the various oral fluid testing seminars. Did you get a chance to read through the write-up done by Mr. Lehman? There's some good stuff in there!

We know that Mr. Lehman owns over 26,000 shares of Lifeloc for his Highway 54 investment fund:

"My investment fund was able to build a $100k + position in less than a month at under $3.8/sh. Volume is out there if you trickle in."

He also stated that Lifeloc is "The best investment idea I’ve found over the last 500 companies or so I’ve looked at since the start of 2024"

Here is the Highway 54 website and more info about the owner Andy Lehman

https://highway54investments.com/home

The man sounds like he really does his homework and tries to attend all the annual shareholder meetings that he makes investments in.

Have you guys ever seen the posts from Andy Lehman who runs a fund called Highway 54? I would recommend reading through both of these updates as they are directly associated with a position in Lifeloc Technologies:

https://substack.com/inbox/post/150052125?r=ox9th&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true&triedRedirect=true

https://www.dropbox.com/scl/fi/9dal42gpe7nscs72vh0kv/LCTC-Final-July-2024.pdf?rlkey=de288oi1z2uq829wt5buosjci&e=1&dl=0

SOBR had a huge move up today > 10 million shares traded

We know that Lifeloc will not be presenting the SpinDx device at the upcoming SAPAA event but I have to think that when the SpinDx is ready to go and it does garner some interest from attendees, buyers, police forces, municipalities, competitors, etc. that's when the fun begins. If it is presented to the right person or group, we could see some fireworks in the stock price. It only takes one or two potential investors who really love the technology to really move this thing.

How much better is it going to be when we know that Lifeloc will be actively presenting the SpinDx device at these conferences and expos. Let's hope it happens soon! How great would Monday have been if this weekends SAPAA conference had Lifeloc providing demonstrations of the SpinDx device to all those attendees.

I agree... If Lifeloc's Market Cap was equal to Cannabix, it would put LCTC's share price over $16.

When I google search "Lifeloc technologies public stock float" the results show:

"As of September 4, 2024, Lifeloc Technologies Inc.'s (LCTC) public stock float was 139,260 shares.
A stock's float is the number of shares that are available for the public to buy and sell. It doesn't include restricted stock held by insiders, but if insiders sell their stock, it becomes part of the float."

Marketwatch.com also confirms that number:

https://www.marketwatch.com/investing/stock/lctc

There just cannot possibly be that many publicly traded shares left that are not being held by long term investors.

Using those float numbers, the entire public market available for non-insiders is valued at just $584,892.

I know I'm not selling anytime soon and I have to imagine those on this board are locked up also so my point is if we get some really market moving news and we don't hold it down with shares to sell, it could move up very quickly just like Energy Manager said. Ideally I would like to see us get up there to at least in-line with the Cannabix valuation before we start seeing the news releases from Lifeloc.

#LCTCNoSharesToSell
#LCTCLockedUp

A quick review of the Cannabix (BLOZF) latest quarterly earnings report continues to show no sales, no revenue, no product, a quarterly loss of $1.25 million, more dilution to current shareholders, and an accumulated deficit of over $38 million. They are spending $14,000 each day to fund activities with no source of revenue and investors continue to value this company 4 times that of Lifeloc. It's time for Lifeloc to finally play some catch up.

I'd love to see some news releases/PR's from Lifeloc regarding the SpinDx progress before the end of this year. Something that will sustain momentum to the upside and bring in some buyers of the stock. Something that catches the attention of investors during the "perfect storm" of upcoming events.

Busy month for Lifeloc:

Upcoming Lifeloc Technologies exhibitor conferences:

SAPAA (Substance Abuse Program Association) Oct. 6th-9th

The ANESTHESIOLOGY 2024 annual meeting October 18th - 22nd

IACP (International Association of Chiefs of Police) Oct. 20th-22nd in Boston, MA

It's probably pretty fair to say that we probably won't hear much about their new product until the next earnings release, which is still over a month away. This should coincide closely with the November election, which I can only see as being a positive for anything marijuana related, due to both candidates stance on legalization.

As I have stated before, it is very important to understand that legalization of cannabis, does not mean that it will be legal to drive an automobile while impaired by marijuana, alcohol, or any other drug of abuse, including OTC drugs. The timing of Lifeloc's new device, that will provide a quantitative measurement of THC in a subject, could not be more appropriate for the "New America" in which we now live, where more adults now use marijuana daily, than alcohol. I would say that Lifeloc has all of the bases covered, and this is setting up to be the "perfect storm..."

I can also say, with some confidence, that all of the recent insiders purchasing their company's stock, did not buy the stock because they feel the price will be going down in the near term. That simply would not make sense. It's my opinion, that a $40 per share price is not unreasonable, and could be obtained very quickly, due to the very tight share structure of Lifeloc's common stock.

Patience...

"Lifeloc will be at SAPAA, exhibiting our core alcohol testing products. The SpinDx is not yet ready for open public display. Yes, we will be in training sessions, staying current on the latest training is important to us as it is a significant part of our revenue."

I believe some of the marijuana/cannabis stocks are moving higher today on this comment:

Kamala Harris Says 'We Need To Legalize' Marijuana For First Time As Democratic Presidential Nominee

Lots of gems in this years Letter to Shareholders:

https://lifeloc.com/pub/media/pdf/shareholderLetter2023.pdf

Our SpinDx™ technology platform or "Lab on a Disk", which we anticipate bringing to market in 2025, consists of a series of devices and tests that can be used at the roadside, in emergency rooms and in workplace testing to obtain a rapid and quantitative measure for a panel of drugs of abuse. The SpinDx reader is the base product, which we anticipate will ship with the ability to read disks for delta-9-THC detection from an oral fluid sample collected from a test subject. With firmware updates, we expect the SpinDx to be able to read future disk offerings for a broader array of drug panels. Firmware updates will be available to customers through a subscription model, with disks and sample collection kits as consumables, together producing a potentially significant recurring revenue stream.

We anticipate that both quantitative and pass/fail disks will be made available, which would make this offering the only rapid, quantitative saliva test for delta-9 THC available on the market. Following this we expect to release a system based on our LX9 breathalyzer to collect a sample for analysis from breath, which, coupled with the SpinDx reader, we expect to complete our marijuana breathalyzer system.

We have improved the detection sensitivity for delta-9-THC as well as the robustness of the device. Our first utility patent application was filed in early 2024 covering some of the improvements that we have made on the SpinDx technology. We are continuing to work on developing this system into an easily portable device that can be used for roadside testing, as well as other venues requiring fast response. We have committed additional personnel and new equipment resources to this effort, with the goal of placing beta test units in 2024 with validation partners who have already been identified. We anticipate full commercialization and revenue contribution to begin in 2025. Human trials have begun validating SpinDx detection of delta-9-THC at the detection limits of 10 ng/ml in real-world human samples. We intend to prioritize the acceleration of SpinDx even at the expense of short-term profitability, with research and development investments, including validation testing, expected to remain high in 2024.